Western blot analysis confirmed that increasing doses of CX-4945 (0, 2, 4, 8 μM) led to a corresponding decrease in BCL-2 protein levels in T-ALL cells (Figure 3d). Here, BCL2 is linked to acute lymphoblastic leukemia.